IP Library Granted Patent US 10,734,126
Granted Patent B2
US 10,734,126 · App. 13/460,033 · Granted Aug 4, 2020

Methods of separating medical isotopes from uranium solutions

Inventor: Gregory Piefer (Middleton, WI)
Assignee: SHINE Medical Technologies, LLC
G21G1/001B01D59/24C01G39/003C01G43/003C22B3/42C22B34/30C22B34/34C22B60/0265G21C19/46G21F9/12G21F9/125G21G2001/0036
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,734,126
App. No.
13/460,033
Granted
Aug 4, 2020
Kind
B2
Abstract

Provided are methods to separate an isotope from a first solution including uranium. The methods may include (a) cleaning the first solution to form a second solution including the uranium and a third solution including the isotope; (b) oxidizing the third solution to form an oxidized isotope; and (c) separating the oxidized isotope.

Claims (28)

1. A method of separating a desired isotope from a first solution comprising uranium, the method comprising:

a) cleaning the first solution to form a second solution comprising uranium and a third solution comprising the desired isotope; then

b) oxidizing the desired isotope; and then

c) applying the third solution to a medium to separate the desired isotope from the third solution, wherein the medium does not include a solvent extraction process, and wherein the desired isotope is selected from the group consisting of Mo-99, I-131, I-125, In-111, Xe-133, Y-90, Pd-103, Ru-106, and Cs-137.

2. The method of claim 1 , wherein step (a) comprises a solvent extraction process.

3. The method of claim 2 , wherein the solvent extraction process comprises a UREX process.

4. The method of claim 3 , wherein the UREX process comprises treating the first solution with an effective amount of tributyl phosphate and acetohydroxamic acid.

5. The method of claim 1 , wherein the desired isotope comprises Mo-99.

6. The method of claim 1 , wherein the first solution comprises uranium in an amount of at least about 10 g/L.

7. The method of claim 1 , wherein the medium of step (c) comprises a metal oxide column.

8. A method of producing desired isotopes, the method comprising:

a) irradiating a uranium solution to form a first solution comprising uranium and a daughter isotope; then

b) contacting the first solution with a chemical separation medium to form a second solution comprising the uranium and a third solution comprising the daughter isotope; and then

c) oxidizing the third solution and then applying the third solution to a medium to separate the daughter isotope from the third solution, wherein the medium does not include a solvent extraction process, and wherein the daughter isotope comprises a desired isotope selected from the group consisting of Mo-99, I-131, I-125, In-111, Xe-133, Y-90, Pd-103, Ru-106, and Cs-137.

9. The method of claim 8 , wherein the uranium solution of step (a) comprises uranium in an amount of at least about 10 g/L.

10. The method of claim 8 , wherein the desired isotope comprises Mo-99.

11. The method of claim 8 , wherein step (b) comprises a solvent extraction process.

12. The method of claim 11 , wherein the solvent extraction process comprises a UREX process.

13. The method of claim 11 , wherein step (b) comprises treating the first solution with an effective amount of tributyl phosphate and acetohydroxamic acid.

14. The method of claim 8 , further comprising returning the uranium from the second solution to a reaction vessel for irradiation.

15. The method of claim 8 , wherein the medium of step (c) comprises an alumina column.

16. A method of producing isotopes, comprising:

a) irradiating a uranium solution to yield a daughter isotope; then

b) separating the remaining uranium from the solution; then

c) oxidizing the daughter isotope; then

d) applying the solution to a medium to separate the daughter isotope from the solution, wherein the medium does not include a solvent extraction process; and then

e) extracting the daughter isotope, wherein the daughter isotope comprises a desired isotope selected from the group consisting of Mo-99, I-131, I-125, In-111, Xe-133, Y-90, Pd-103, Ru-106, and Cs-137.

17. The method of claim 16 , further comprising returning the remaining uranium in step (b) to step (a) for irradiation.

Assignments (4)
CHANGE OF NAME Recorded Oct 15, 2021
From: SHINE MEDICAL TECHNOLOGIES, LLC
To: SHINE TECHNOLOGIES, LLC
Reel/Frame 057827/0843 →
CERTIFICATE OF CONVERSION AND CHANGE OF NAME Recorded Jan 11, 2021
From: SHINE MEDICAL TECHNOLOGIES, INC.
To: SHINE MEDICAL TECHNOLOGIES, LLC
Reel/Frame 054960/0567 →
SECURITY INTEREST Recorded Nov 20, 2018
From: SHINE MEDICAL TECHNOLOGIES, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P.
Reel/Frame 047555/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2012
From: PIEFER, GREGORY
To: SHINE MEDICAL TECHNOLOGIES, INC.
Reel/Frame 028141/0136 →
Continuity (2)
Provisional Application 61480214 · Apr 28, 2011
Related Publication 20120300891A1 · Nov 29, 2012